Agnieszka Nikiforuk, PhD - Publications

Affiliations: 
Behavioral Neuroscience Institute of Pharmacology, Polish Academy of Sciences 
Area:
neuroscience, behavioral neuropharmacology, rodent behavior, animal models of psychiatric disorders, cognitive

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats. Journal of Psychopharmacology (Oxford, England). 269881119867603. PMID 31452444 DOI: 10.1177/0269881119867603  1
2019 Hogendorf AS, Hogendorf A, Kurczab R, Kalinowska-Tłuścik J, Popik P, Nikiforuk A, Krawczyk M, Satała G, Lenda T, Knutelska J, Bugno R, Staroń J, Pietruś W, Matłoka M, Dubiel K, et al. 2-Aminoimidazole-based antagonists of the 5-HT receptor - A new concept in aminergic GPCR ligand design. European Journal of Medicinal Chemistry. 179: 1-15. PMID 31229883 DOI: 10.1016/j.ejmech.2019.06.001  1
2018 Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors. Journal of Psychopharmacology (Oxford, England). 269881118812097. PMID 30501536 DOI: 10.1177/0269881118812097  1
2018 Potasiewicz A, Holuj M, Piotrowska D, Zajda K, Wojcik M, Popik P, Nikiforuk A. Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats. Neuropharmacology. PMID 30448422 DOI: 10.1016/j.neuropharm.2018.11.023  1
2018 Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Nikiforuk A, Nalepa I, et al. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. European Journal of Medicinal Chemistry. 145: 790-804. PMID 29407591 DOI: 10.1016/j.ejmech.2018.01.002  1
2017 Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G. A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats. Frontiers in Behavioral Neuroscience. 11: 222. PMID 29230168 DOI: 10.3389/fnbeh.2017.00222  1
2017 Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, Kos T, Popik P. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research. PMID 28433499 DOI: 10.1016/j.schres.2017.04.014  1
2017 Potasiewicz A, Nikiforuk A, Hołuj M, Popik P. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats. Journal of Psychopharmacology (Oxford, England). 31: 260-271. PMID 28168926 DOI: 10.1177/0269881116675509  1
2016 Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology. PMID 27717880 DOI: 10.1016/j.neuropharm.2016.10.002  1
2016 Nikiforuk A, Potasiewicz A, Kos T, Popik P. The combination of memantine and galantamine improves cognition in rats: the synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Behavioural Brain Research. PMID 27435422 DOI: 10.1016/j.bbr.2016.07.023  1
2016 Nikiforuk A, Hołuj M, Kos T, Popik P. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Neuropharmacology. PMID 26826431 DOI: 10.1016/j.neuropharm.2016.01.035  1
2015 Nikiforuk A, Potasiewicz A, Rafa D, Drescher K, Bespalov A, Popik P. The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors. Behavioural Pharmacology. PMID 26580130 DOI: 10.1097/FBP.0000000000000201  1
2015 Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 172: 5123-35. PMID 26276349 DOI: 10.1111/bph.13277  1
2015 Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Neuropharmacology. 101: 389-400. PMID 26232639 DOI: 10.1016/j.neuropharm.2015.07.034  1
2015 Popik P, Nikiforuk A. Attentional Set-Shifting Paradigm in the Rat. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. 72: 9.51.1-9.51.13. PMID 26131663 DOI: 10.1002/0471142301.ns0951s72  1
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1300-13. PMID 26003081 DOI: 10.1016/j.euroneuro.2015.04.018  1
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats. Behavioural Brain Research. 289: 149-56. PMID 25930219 DOI: 10.1016/j.bbr.2015.04.030  1
2015 Ho?uj M, Popik P, Nikiforuk A. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Behavioural Pharmacology. PMID 25769091 DOI: 10.1097/FBP.0000000000000132  1
2015 Nikiforuk A. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date. Cns Drugs. 29: 265-75. PMID 25721336 DOI: 10.1007/s40263-015-0236-0  1
2015 Popik P, Holuj M, Nikiforuk A, Kos T, Trullas R, Skolnick P. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38. PMID 25260339 DOI: 10.1007/s00213-014-3738-4  1
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats European Neuropsychopharmacology. 25: 1300-1313. DOI: 10.1016/j.euroneuro.2015.04.018  1
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats Behavioural Brain Research. 289: 149-156. DOI: 10.1016/j.bbr.2015.04.030  1
2014 Rygula R, Szczech E, Papciak J, Nikiforuk A, Popik P. The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Behavioural Brain Research. 270: 206-12. PMID 24859175 DOI: 10.1016/j.bbr.2014.05.026  1
2014 Nikiforuk A, Popik P. The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1381-93. PMID 24846536 DOI: 10.1016/j.euroneuro.2014.04.007  1
2014 Nikiforuk A. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia. Reviews in the Neurosciences. 25: 367-82. PMID 24501158 DOI: 10.1515/revneuro-2014-0005  1
2014 Nikiforuk A, Popik P. Ketamine prevents stress-induced cognitive inflexibility in rats. Psychoneuroendocrinology. 40: 119-22. PMID 24485483 DOI: 10.1016/j.psyneuen.2013.11.009  1
2014 Popik P, Kos T, Pluta H, Nikiforuk A, Rojek K, RyguÅ‚a R. Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations. Behavioural Brain Research. 260: 53-7. PMID 24308957 DOI: 10.1016/j.bbr.2013.11.029  1
2014 FijaÅ‚ K, Popik P, Nikiforuk A. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats. Psychopharmacology. 231: 269-81. PMID 23954911 DOI: 10.1007/s00213-013-3234-2  1
2013 Nikiforuk A, Popik P. Neurochemical modulation of stress-induced cognitive inflexibility in a rat model of an attentional set-shifting task. Pharmacological Reports : Pr. 65: 1479-88. PMID 24552995  1
2013 Nikiforuk A, Kos T, FijaÅ‚ K, HoÅ‚uj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Plos One. 8: e66695. PMID 23776692 DOI: 10.1371/journal.pone.0066695  1
2013 Nikiforuk A, Popik P. Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behavioural Brain Research. 248: 136-40. PMID 23603557 DOI: 10.1016/j.bbr.2013.04.008  1
2013 Nikiforuk A, FijaÅ‚ K, Potasiewicz A, Popik P, Kos T. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats. Journal of Psychopharmacology (Oxford, England). 27: 469-76. PMID 23479455 DOI: 10.1177/0269881113480991  1
2013 Nikiforuk A. Quetiapine ameliorates stress-induced cognitive inflexibility in rats. Neuropharmacology. 64: 357-64. PMID 22750412 DOI: 10.1016/j.neuropharm.2012.06.042  1
2012 Nikiforuk A. Dopamine D1 receptor modulation of set shifting: the role of stress exposure. Behavioural Pharmacology. 23: 434-8. PMID 22743605 DOI: 10.1097/FBP.0b013e328356522f  1
2012 Nikiforuk A. Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behavioural Brain Research. 226: 118-23. PMID 21925545 DOI: 10.1016/j.bbr.2011.09.006  1
2012 Nikiforuk A, Popik P. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology. 220: 65-74. PMID 21918808 DOI: 10.1007/s00213-011-2487-x  1
2011 Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology. 61: 262-7. PMID 21530555 DOI: 10.1016/j.neuropharm.2011.04.010  1
2011 Nikiforuk A, Kos T, WesoÅ‚owska A. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology. 217: 411-8. PMID 21499701 DOI: 10.1007/s00213-011-2297-1  1
2011 Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology. 214: 911-21. PMID 21161188 DOI: 10.1007/s00213-010-2102-6  1
2011 Nikiforuk A, Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psychoneuroendocrinology. 36: 28-39. PMID 20580164 DOI: 10.1016/j.psyneuen.2010.06.001  1
2010 Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, Bespalov A. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. The Journal of Pharmacology and Experimental Therapeutics. 335: 665-73. PMID 20739457 DOI: 10.1124/jpet.110.170506  1
2010 Nikiforuk A, GoÅ‚embiowska K, Popik P. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 37-48. PMID 19729284 DOI: 10.1016/j.euroneuro.2009.08.001  1
2009 Zagórska A, Jurczyk S, PawÅ‚owski M, DybaÅ‚a M, Nowak G, TatarczyÅ„ska E, Nikiforuk A, Chojnacka-Wójcik E. Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives. European Journal of Medicinal Chemistry. 44: 4288-96. PMID 19679379 DOI: 10.1016/j.ejmech.2009.07.014  1
2009 Nikiforuk A, Popik P. Antidepressants alleviate the impact of reinforcer downshift. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 41-8. PMID 18805678 DOI: 10.1016/j.euroneuro.2008.08.002  1
2008 WesoÅ‚owska A, Nikiforuk A. The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats. European Journal of Pharmacology. 582: 88-93. PMID 18234190 DOI: 10.1016/j.ejphar.2007.12.013  1
2007 Paluchowska MH, Bugno R, DuszyÅ„ska B, TatarczyÅ„ska E, Nikiforuk A, Lenda T, Chojnacka-Wójcik E. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines. Bioorganic & Medicinal Chemistry. 15: 7116-25. PMID 17825569 DOI: 10.1016/j.bmc.2007.07.029  1
2007 WesoÅ‚owska A, Nikiforuk A, Stachowicz K. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behavioural Pharmacology. 18: 439-46. PMID 17762512 DOI: 10.1097/FBP.0b013e3282d28f9c  1
2007 ChÅ‚oÅ„-Rzepa G, Zmudzki P, Zajdel P, Bojarski AJ, DuszyÅ„ska B, Nikiforuk A, TatarczyÅ„ska E, PawÅ‚owski M. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands. Bioorganic & Medicinal Chemistry. 15: 5239-50. PMID 17517514 DOI: 10.1016/j.bmc.2007.05.017  1
2007 Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E. Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. The Journal of Pharmacology and Experimental Therapeutics. 321: 1208-25. PMID 17325229 DOI: 10.1124/jpet.106.116483  1
2007 Zajdel P, Subra G, Bojarski AJ, DuszyÅ„ska B, TatarczyÅ„ska E, Nikiforuk A, Chojnacka-Wójcik E, PawÅ‚owski M, Martinez J. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Bioorganic & Medicinal Chemistry. 15: 2907-19. PMID 17321139 DOI: 10.1016/j.bmc.2007.02.018  1
2007 WesoÅ‚owska A, Nikiforuk A. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology. 52: 1274-83. PMID 17320917 DOI: 10.1016/j.neuropharm.2007.01.007  1
2007 WesoÅ‚owska A, TatarczyÅ„ska E, Nikiforuk A, Chojnacka-Wójcik E. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. European Journal of Pharmacology. 555: 43-7. PMID 17109856 DOI: 10.1016/j.ejphar.2006.10.001  1
2006 WesoÅ‚owska A, Nikiforuk A, Stachowicz K. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. European Journal of Pharmacology. 553: 185-90. PMID 17097082 DOI: 10.1016/j.ejphar.2006.09.064  1
2006 WesoÅ‚owska A, Nikiforuk A, Stachowicz K, TatarczyÅ„ska E. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology. 51: 578-86. PMID 16828124 DOI: 10.1016/j.neuropharm.2006.04.017  1
2006 WesoÅ‚owska A, Nikiforuk A, Chojnacka-Wójcik E. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. European Journal of Pharmacology. 541: 57-63. PMID 16765343 DOI: 10.1016/j.ejphar.2006.04.049  1
2006 WesoÅ‚owska A, Nikiforuk A, Michalska K, Kisiel W, Chojnacka-Wójcik E. Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. Journal of Ethnopharmacology. 107: 254-8. PMID 16621374 DOI: 10.1016/j.jep.2006.03.003  1
2006 Obniska J, TatarczyÅ„ska E, Nikiforuk A, Charakchieva-Minol S, DuszyÅ„ska B. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione. Pharmacological Reports : Pr. 58: 107-14. PMID 16531637  1
2004 DabroÅ› W, Nikiforuk A, Kordowiak AM. Morphology and biochemical activity of rat liver golgi complexes after pretreatment with bis(kojato)oxovanadium(IV) or kojic acid alone. Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists. 55: 15-21. PMID 15619976  1
2004 Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, Mühldorfer S. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Digestive Diseases and Sciences. 49: 1075-83. PMID 15387324 DOI: 10.1023/B:DDAS.0000037790.11724.70  1
2004 Konturek PC, Brzozowski T, Pajdo R, Nikiforuk A, Kwiecien S, Harsch I, Drozdowicz D, Hahn EG, Konturek SJ. Ghrelin-a new gastroprotective factor in gastric mucosa. Journal of Physiology and Pharmacology : An Official Journal of the Polish Physiological Society. 55: 325-36. PMID 15213356  1
2004 Brzozowski T, Konturek PC, Konturek SJ, KwiecieÅ„ S, Drozdowicz D, Bielanski W, Pajdo R, Ptak A, Nikiforuk A, Pawlik WW, Hahn EG. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regulatory Peptides. 120: 39-51. PMID 15177919 DOI: 10.1016/j.regpep.2004.02.010  1
2004 Konturek PC, Nikiforuk A, Brzozowski T, Pawlik M, Raithel M, Hahn EG, Konturek SJ. Effect of N-alpha-methyl histamine on ulcer healing in rats. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 53: S27-8. PMID 15054603 DOI: 10.1007/s00011-003-0312-7  1
2003 Konturek PC, Kania J, Konturek JW, Nikiforuk A, Konturek SJ, Hahn EG. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 9: SR53-66. PMID 12883469  1
2000 Kordowiak AM, Nikiforuk A, DabroÅ› W. Biochemical and morphological study on liver Golgi complex in streptozotocin-diabetic and control rats treated with bis(kojato)oxovanadium(IV) [VO(ka)2]x2H2O. Part I. One week treatment with vanadium compound. Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists. 51: 9-16. PMID 10833898  1
Show low-probability matches.